KR102605808B1 - Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function - Google Patents

Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function Download PDF

Info

Publication number
KR102605808B1
KR102605808B1 KR1020200102845A KR20200102845A KR102605808B1 KR 102605808 B1 KR102605808 B1 KR 102605808B1 KR 1020200102845 A KR1020200102845 A KR 1020200102845A KR 20200102845 A KR20200102845 A KR 20200102845A KR 102605808 B1 KR102605808 B1 KR 102605808B1
Authority
KR
South Korea
Prior art keywords
calcium
phosphate
complex
producing
clause
Prior art date
Application number
KR1020200102845A
Other languages
Korean (ko)
Other versions
KR20220021915A (en
Inventor
김희래
Original Assignee
주식회사 아이디어앤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아이디어앤 filed Critical 주식회사 아이디어앤
Priority to KR1020200102845A priority Critical patent/KR102605808B1/en
Publication of KR20220021915A publication Critical patent/KR20220021915A/en
Application granted granted Critical
Publication of KR102605808B1 publication Critical patent/KR102605808B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • C01B25/26Phosphates
    • C01B25/32Phosphates of magnesium, calcium, strontium, or barium
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • A01N59/20Copper
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/80Particles consisting of a mixture of two or more inorganic phases
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/90Other properties not specified above

Abstract

본 발명은 바이러스 흡착 및 사멸화 기능의 복합체 제조방법에 관한 것으로서, 보다 상세하게는 바이러스 흡착 특성이 있는 수산화아파타이트와 바이러스 사멸 특성을 갖는 구리나 백금의 복합 소재를 제조하는 방법에 관한 것이다. The present invention relates to a method for producing a composite with virus adsorption and killing properties, and more specifically, to a method for producing a composite material of hydroxyapatite with virus adsorption properties and copper or platinum with virus killing properties.

Description

바이러스 흡착-차단 및 사멸-불활성화 기능의 복합소재 제조방법 { Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function }Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function }

21세기 들어오면서 2002년 사스(SARS, 중증급성호흡기), 2009년 신종인플루엔자(신종플루), 2015년 메르스(MERS, 중동호흡기증후군), 2019년 코로나19 (COVID-19, 코로나바이러스감염증 -19)와 같은 인체 전염성이 높고 사망 위험이 높은 신종 바이러스의 출현이 빈번해지고 있으며, 그 출현 주기가 짧아지고 있다. 그리고 세계화에 따라 국가간 이동/도시화 및 국가 간 이동이 용이하여 그 확산 속도가 빠르고 사회적, 경제적 피해가 급증하고 있으며 신종 바이러스들의 변이가 빠르게 일어나고 있다. 또한 신종 바이러스 출현에 따라 백신 및 치료제의 개발에 소요되는 시간이 길어질 수 있는 문제가 있다. 따라서 바이러스를 효과적으로 차단할 수 있는 개인 및 생활 방역 제품에 적용할 소재가 필요하다. Entering the 21st century, SARS (severe acute respiratory syndrome) in 2002, swine flu (swine flu) in 2009, MERS (Middle East respiratory syndrome) in 2015, and COVID-19 (coronavirus infection -19) in 2019 ), the emergence of new viruses with high human contagiousness and high risk of death is becoming more frequent, and their emergence cycle is shortening. And with globalization, movement/urbanization and movement between countries are easy, so the spread is fast, social and economic damage is rapidly increasing, and new viruses are rapidly mutating. Additionally, there is a problem that the time it takes to develop vaccines and treatments may increase as new viruses emerge. Therefore, materials that can be applied to personal and household quarantine products that can effectively block viruses are needed.

수산화아파타이트는 인체의 치아나 뼈를 구성하는 무기질 성분으로서, 생체 세라믹 소재로 생체 대체 재료 등 의료용 소재로 주로 사용되고 있으며, 양이온 및 음이온 교환 특성을 모두 가지고 있기 때문에 고순도 바이오 의약품 정제를 위한 고성능 흡착 소재로 사용되고 있다. 따라서 RNA, Viruses, Membrane Proteins, Vaccines, Polyclonal & Monoclonal Antibodies, DNA, Antibody Fragment 등의 흡착 및 분리에 사용되고 있다. Hydroxyapatite is an inorganic component that makes up the teeth and bones of the human body, and is mainly used as a medical material such as a bioceramic material and bioreplacement material. Since it has both cation and anion exchange properties, it is a high-performance adsorption material for purifying high-purity biopharmaceuticals. It is being used. Therefore, it is used for adsorption and separation of RNA, Viruses, Membrane Proteins, Vaccines, Polyclonal & Monoclonal Antibodies, DNA, Antibody Fragment, etc.

그리고, 금속성 이온은 일반적으로 살균 특성을 보이며, 직접 접촉을 통하여 미량의 금속 이온이 미생물의 대사 작용을 교란해 죽이는 미량 동작용을 가지고 있다. 이 중 구리는 구리 이온이 바이러스 외부 세포를 뚫고 침투하여 세포막을 파괴시키고, 세포 손상을 가속화시켜 바이러스 내부의 DNA를 손상시켜 사멸시키는 작용을 한다. 또한 바이러스 파괴 효과가 매우 탁월하고 이론적으로는 모든 종류의 바이러스에 효과가 있을 수 있다고 보고되고 있다. 그리고, 백금도 세균 바이러스와 접촉하여 단백질이나 DNA를 파괴하는 것으로 알려져 있다. In addition, metallic ions generally exhibit sterilizing properties, and have the effect of causing trace amounts of metal ions to disrupt the metabolic function of microorganisms and kill them through direct contact. Among these, copper ions penetrate through the outer cells of the virus, destroying the cell membrane and accelerating cell damage, damaging the DNA inside the virus and killing it. It is also reported that it has an excellent virus destruction effect and theoretically can be effective against all types of viruses. Also, platinum is known to destroy proteins and DNA when it comes into contact with bacterial viruses.

따라서, 다양한 바이러스에 대한 높은 흡착 특성을 보이는 수산화아파타이트와 바이러스 사멸화 특성이 있는 구리나 백금의 복합화를 통하여 바이러스의 흡착-차단 및 사멸-불활성화 특성의 복합 소재의 발명에 이르게 되었다. Accordingly, the invention of a composite material with virus adsorption-blocking and killing-inactivation properties was achieved through the combination of hydroxyapatite, which shows high adsorption properties for various viruses, and copper or platinum, which have virus killing properties.

바이러스 사멸 효과가 있는 구리나 백금은 바이러스와의 접촉이 되어야만 바이러스에 대한 사멸 작용을 기대할 수 있어 바이러스와 접촉이 이루어지지 않는다면 바이러스의 사멸 기능은 거의 기대할 수 없는 문제점이 있다. 따라서 바이러스 사멸-불활성화에 효과가 있는 구리나 백금 이온이 직접적으로 작용할 수 있도록 하는 것이 필요하다. Copper or platinum, which have a virus-killing effect, can only be expected to have a virus-killing effect if they come into contact with the virus. Therefore, if they do not come into contact with the virus, there is a problem that the virus-killing function can hardly be expected. Therefore, it is necessary to allow copper or platinum ions, which are effective in killing and inactivating viruses, to act directly.

따라서, 본 발명은 바이러스 흡착-차단 및 사멸-불활성화 기능의 복합체 제조방법에 관한 것으로서, DNA, RNA, 단백질, 항체, 바이러스 등에 대한 흡착 특성이 있는 수산화아파타이트에 바이러스 사멸화 특성이 있는 구리나 백금 이온을 결합시킨 바이러스 흡착-차단 및 사멸-불활성화가 가능한 복합 소재를 제조하는 방법에 관한 것이다. Therefore, the present invention relates to a method of manufacturing a complex with virus adsorption-blocking and killing-inactivation functions, in which hydroxyapatite, which has adsorption properties for DNA, RNA, proteins, antibodies, viruses, etc., is mixed with copper or platinum, which have virus killing properties. It relates to a method of manufacturing a composite material capable of adsorption-blocking and killing-inactivating viruses by combining ions.

수산화아파타이트와 금속이온의 복합체는 국내특허등록 10-1764596, 국내특허출원 10-2017 -0049388와 같이 은을 이용한 항균성을 부여하는 경우와, 국내특허등록 10-2051622와 같이 견운모, 실리타졸 등의 무기질에 은,구리,아연 등과 복합화한 무기항균제를 제조하는 방법들이 있다. 하지만 상기 방법들은 여러 반응을 거치거나 600~1300도의 고온에서 소결처리 과정을 거쳐는 등 공정이 복잡하고 높은 제조 비용이 소요될 수 있다는 단점이 있다. Complexes of hydroxyapatite and metal ions provide antibacterial properties using silver, such as domestic patent registration 10-1764596 and domestic patent application 10-2017-0049388, and minerals such as sericite and silitasol, as shown in domestic patent registration 10-2051622. There are methods for producing inorganic antibacterial agents complexed with silver, copper, zinc, etc. However, the above methods have the disadvantage of requiring complex processes and high manufacturing costs, such as requiring multiple reactions or sintering at high temperatures of 600 to 1,300 degrees.

따라서, 본 발명에서는 다양한 바이러스의 흡착-차단 및 사멸-불활성화를 위한 수산화아파타이트와 구리나 백금 복합 소재를 다양한 위생/방역 제품에 응용될 수 있도록 단순화된 공정 및 저비용의 경제적인 방법으로 제조하는 것이다. Therefore, in the present invention, a composite material of hydroxyapatite and copper or platinum for adsorption-blocking and killing-inactivation of various viruses is manufactured through a simplified process and low-cost, economical method so that it can be applied to various hygiene/quarantine products. .

상기 과제를 해결하기 위하여 많은 예의 검토를 거쳐 본 발명에 이르럿다. In order to solve the above problems, we have arrived at the present invention after much careful study.

본 발명에 따른 바이러스 차단 복합소재에 있어 상기 과제를 해결하기 위하여 (1) 칼슘염 함유 물질 및 인산염 함유 물질 및 금속염을 혼합하는 단계; (2) 상기 (1)혼합물에 약산성에서 강알칼리성의 수용액을 첨가하는 단계; (3) 상기 (2)혼합물을 Ball Mill 시켜 반응시키는 단계; (4) 상기(3) 반응물을 건조 및 분쇄하는 단계로 구성되고 상기 과정들로 바이러스 흡착-차단 및 사멸-불활성화 복합 소재를 제조한는 것을 특징으로 한다. In order to solve the above problems in the virus blocking composite material according to the present invention, (1) mixing a calcium salt-containing material, a phosphate-containing material, and a metal salt; (2) adding a weakly acidic to strongly alkaline aqueous solution to the mixture of (1); (3) reacting the mixture (2) by ball milling; (4) It consists of the step of drying and pulverizing the reactant of (3), and the above processes are used to produce a virus adsorption-blocking and killing-inactivation composite material.

본 발명의 (1) 단계는 칼슘염 함유 물질 및 인산염 함유 물질 및 금속염 물질로 구성된 혼합물을 제조하는 것이다. 상기 혼합물을 제조하는 방법으로 칼슘염 및 인산염의 몰비, 즉 Ca/P 몰 비는 1.0 ~ 2.0으로 하며 가장 바람직한 Ca/P 몰비는 1.6 ~ 1.8이고, 금속염은 칼슘염 및 인산염 함유 물질 총합의 0.1 ~ 20% 중량비로 첨가하고 가장 바람직한 함유량은 0.5 ~ 5% 중량비이다. Step (1) of the present invention is to prepare a mixture composed of a calcium salt-containing material, a phosphate-containing material, and a metal salt material. By preparing the above mixture, the molar ratio of calcium salt and phosphate, that is, Ca/P molar ratio, is 1.0 to 2.0. The most preferable Ca/P molar ratio is 1.6 to 1.8, and the metal salt is 0.1 to 0.1 of the total calcium salt and phosphate-containing materials. It is added at a weight ratio of 20%, and the most preferred content is 0.5 to 5% by weight.

(1)단계의 칼슘염 공급원으로는 수산화칼슘, 탄산칼슘, 염화칼슘, 질산칼슘, 산화칼슘, 황산칼슘, 규산칼슘, 글루콘산칼슘, 비산칼슘, 아세트산칼슘, 브로화칼슘, 글리세른인산칼슘, 젖산칼슘, 구연산칼슘, 피로피온산칼슘, 아스코트빈산칼슘 및 그들의 무수화물 및 수화물, 사칼슘인산염, 인산삼칼슘, 인산팔칼슘, 이수화인산디칼슘, 인산이칼슘, 피로인산칼슘, 이수화칼슘피로인산, 인산이수소칼슘, 메타인산칼슘으로 구성된 군에서 선택하여 사용한다. 인산염의 공급원으로는 오르토인산, 오산화인, 제일인산암모늄, 제이인산암모늄, 메타인산, 피로인산, 제이인산나트륨, 삼인산, 사인산, 제이인산칼륨, 제이인산마그네슘, 제삼인삼칼륨, 제삼인산나트륨, 제일인산나트륨, 제일인산칼륨, 염화포스포릴, 폴리메타인산, 제삼인산마그네슘, 사칼슘인산염, 인산삼칼슘, 인산팔칼슘, 이수화인산디칼슘, 인산이칼슘, 피로인산칼슘, 이수화칼슘피로인산, 인산이수소칼슘, 메타인산칼슘으로 구성하는 군에서 선택하여 사용하면 된다. 금속염의 공급원으로는 염화제일구리, 염화제이구리, 요오드화제일구리, 질산구리, 피로인산구리, 황산구리 등의 구리화합물 또는 염화백금산, 산화백금, 이산화백금, 염화제이백금, 염화제일백금, 백금염화수소산염, 수산화백금, 질산백금 등 백금화합물을 구성하는 군에서 선택하여 사용하면 된다. Calcium salt sources in step (1) include calcium hydroxide, calcium carbonate, calcium chloride, calcium nitrate, calcium oxide, calcium sulfate, calcium silicate, calcium gluconate, calcium arsenate, calcium acetate, calcium broride, calcium glycerine phosphate, and calcium lactate. , calcium citrate, calcium pyropiionate, calcium ascotate and their anhydrates and hydrates, tetracalcium phosphate, tricalcium phosphate, octalcalcium phosphate, dicalcium phosphate dihydrate, dicalcium phosphate, calcium pyrophosphate, dihydrate calcium pyrophosphate, It is used by selecting from the group consisting of calcium dihydrogen phosphate and calcium metaphosphate. Sources of phosphate include orthophosphoric acid, phosphorus pentoxide, ammonium monophosphate, ammonium diphosphate, metaphosphoric acid, pyrophosphate, sodium diphosphate, triphosphate, phosphoric acid, potassium diphosphate, magnesium diphosphate, tripotassium phosphate, sodium phosphate, Monobasic sodium phosphate, monobasic potassium phosphate, phosphoryl chloride, polymetaphosphate, tricalcium phosphate, tetracalcium phosphate, tricalcium phosphate, octacalcium phosphate, dicalcium phosphate dihydrate, dicalcium phosphate, calcium pyrophosphate, dihydrate calcium pyrophosphate, It can be used by selecting from the group consisting of calcium dihydrogen phosphate and calcium metaphosphate. Sources of metal salts include copper compounds such as cuprous chloride, cupric chloride, cuprous iodide, copper nitrate, copper pyrophosphate, and copper sulfate, or chloroplatinic acid, platinum oxide, platinum dioxide, platinum chloride, platinum chloride, and platinum hydrochloride. , platinum hydroxide, platinum nitrate, etc. can be selected from the group consisting of platinum compounds.

(2) 단계는 상기 (1) 단계에서 제조된 칼슘염, 인산염, 금속염 물질 혼합물에 수용액을 첨가하고 그 수용액을 약산성에서 강알칼리성으로 조절하는 단계로, 본 단계에서 수용액의 pH를 조절하기 위한 방법으로 무기염류를 직접 첨가하거나 무기염류를 혼합한 알칼리 수용액을 이용하여 pH를 조절하면 된다. 이 때의 약산성 및 강알칼리성이 되는 수용액의 pH는 pH 6.0 ~ pH 14.0으로 본 발명에 따르면 pH 7.0 ~ pH 10.0이 가장 적당하다. pH가 너무 낮으면 반응성이 낮아져 칼슘염과 인산염의 반응으로 인한 수산화아파타이트의 생성이 늦어질수 있고, pH가 너무 높으면 반응 후 복합 소재의 pH가 너무 높아질수 있다. pH가 높을경우 인체와 비접촉 제품에 적용할 경우 큰 문제는 없지만, 인체 접촉 제품에 적용할 경우 알레르기 반응을 야기할 수 있다. Step (2) is a step of adding an aqueous solution to the mixture of calcium salts, phosphates, and metal salts prepared in step (1) above and adjusting the aqueous solution from weakly acidic to strongly alkaline. A method for controlling the pH of the aqueous solution in this step. You can adjust the pH by adding inorganic salts directly or using an aqueous alkaline solution mixed with inorganic salts. At this time, the pH of the weakly acidic and strongly alkaline aqueous solution is pH 6.0 to pH 14.0, and according to the present invention, pH 7.0 to pH 10.0 is most appropriate. If the pH is too low, the reactivity may be low and the formation of hydroxyapatite due to the reaction between calcium salt and phosphate may be delayed, and if the pH is too high, the pH of the composite material may become too high after the reaction. If the pH is high, there is no major problem when applied to products that do not come into contact with the human body, but when applied to products that come into contact with the human body, it may cause an allergic reaction.

염기성 공급원으로는 수산화나트륨, 수산화칼륨, 암모니아, 수산화리듐, 수산화칼슘, 수산화 마그네슘 등 알칼리성 화합물로 구성된 군에서 선택하면 된다. The basic source may be selected from the group consisting of alkaline compounds such as sodium hydroxide, potassium hydroxide, ammonia, lithium hydroxide, calcium hydroxide, and magnesium hydroxide.

(3) 단계는 상기 (1) 단계 및 (2) 단계의 과정의 혼합물을 Ball Mill 시켜 반응시키는 단계로, 본 단계에서 습식 반응 및 볼밀에 의하여 혼합물들이 반응하여 수산화아파타이트로의 빠른 변환이 일어나게 되고, 첨가한 금속염 물질인 구리 또는 백금이 보다 용이하게 수산화아파타이트 결정 구조내로 치환이 이루어지게 된다. Ball Mill은 100Rpm ~ 400Rpm의 속도로 하며 가장 바람직한 속도는 200Rpm ~ 300RpM이다. (2)단계에서 적절한 pH로 조절된 수용액과 혼합물이 첨가된 수용액은 Ball Mill 온도를 10℃ ~ 110℃로 하고 1시간 ~ 240시간 동안 반응시킨다. 가장 바람직한 것은 25℃ ~ 80℃로 하고 24시간 ~ 72시간으로 Ball Mill 반응시키는 것이다. Ball Mill시켜 반응시킬 경우 속도 및 온도가 높을 수록 빠른 시간내에 반응 및 치환이 일어나게 된다. 반응 온도는 실온으로 하는것도 무방하나, 실온으로 할 경우 반응 시간이 늘어날 수 있다. Step (3) is a step of reacting the mixture of steps (1) and (2) by ball milling. In this step, the mixture is reacted by wet reaction and ball milling, and rapid conversion to hydroxyapatite occurs. , the added metal salt material, copper or platinum, is more easily substituted into the hydroxyapatite crystal structure. Ball milling operates at a speed of 100Rpm to 400Rpm, with the most desirable speed being 200Rpm to 300RpM. In step (2), the aqueous solution adjusted to an appropriate pH and the aqueous solution added with the mixture are reacted for 1 hour to 240 hours at a ball mill temperature of 10℃ to 110℃. Most preferably, the ball mill reaction is performed at 25°C to 80°C for 24 to 72 hours. When reacting by ball milling, the higher the speed and temperature, the faster the reaction and substitution occur. The reaction temperature may be set to room temperature, but if set to room temperature, the reaction time may increase.

(4) 단계는 상기 (3)단계의 과정을 거친 복합체를 건조 및 분쇄하는 단계로, 본 단계에서는 합성된 복합체를 원심분리기나 필터를 통하여서 여과하면 된다. 여과시 입자 크기에 따라 필터 페이퍼의 기공 사이즈를 선택하여 사용하면 되고 원심분리기는 1,000RPM ~ 10,000RPM의 속도로, 가장 바람직하게는 3,000RPM ~ 5,000RPM의 속도로 여과하면 된다. 여과된 복합체는 100℃ ~ 500℃의 온도로 건조하고, 가장 바람직하게는 150℃ ~ 200℃로 건조를 한다. 건조된 복합체는 분쇄기를 이용하여 분쇄를 한다. 분쇄는 조분쇄기를 통하여 1mm 이하로 조쇄하고 미분쇄기를 통하여 50um 이하로 분쇄하여 복합체 미분말을 제조하면 된다. Step (4) is a step of drying and pulverizing the complex that has gone through the process of step (3) above. In this step, the synthesized complex can be filtered through a centrifuge or filter. During filtration, the pore size of the filter paper can be selected and used depending on the particle size, and the centrifuge can be used to filter at a speed of 1,000 RPM to 10,000 RPM, most preferably 3,000 RPM to 5,000 RPM. The filtered complex is dried at a temperature of 100°C to 500°C, most preferably at 150°C to 200°C. The dried composite is pulverized using a grinder. For grinding, grind to 1 mm or less through a coarse grinder and grind to 50 um or less through a fine grinder to produce composite fine powder.

또한, 섬유 등 고분자나 금속, 세라믹 등에 표면 처리하거나 복합 매트릭스를 제조할 원료로서 사용할 경우 상기 (4)단계의 과정을 생략하고 (3) 단계까지의 과정만으로 제조된 복합체를 응용하는 것도 가능하다. In addition, when using it as a raw material for surface treatment of polymers such as fibers, metals, ceramics, etc. or for manufacturing a composite matrix, it is possible to omit the process of step (4) above and apply the composite manufactured only through the process up to step (3).

따라서, 본 발명으로 제조한 구리/백금이 함유된 수산화아파타이트 즉, 바이러스 흡착-차단 및 사멸-불활성화 복합체를 이용하여 마스크, 공기청정기 등의 필터, 생활 방역 용품 또는 바이러스 차단을 위한 의료용 및 군사용 제품에 응용할 수 있다. Therefore, the copper/platinum-containing hydroxyapatite produced by the present invention, that is, the virus adsorption-blocking and killing-inactivation complex, can be used to manufacture filters such as masks and air purifiers, household quarantine products, and medical and military products for blocking viruses. It can be applied to.

본 발명은 다음과 같은 효과가 있다. The present invention has the following effects.

최근 전세계적으로 전염성을 보인 신종인플루엔자(신종플루)와 같은 인플루엔자 바이러스와 중증급성호흡기증후군(사스, SARS-CoV)), 중동호흡기증후군(메르스, MERS-CoV), 코로나바이러스감염증-19(코로나19, COVID-19)와 같은 코로나바이러스를 효과적으로 차단시키는 것이 중요하다. 특히 과거 사스, 메르스의 경우에는 증상이 없으면 전파력이 없었으나 코로나19는 무증상에서도 전파력이 매우 높다는 위험성이 있고 바이러스의 다양한 변이가 일어나고 있다. 따라서 신종 바이러스 출현과 같은 다양한 바이러스 및 변종 바이러스를 원천적으로 차단 가능한 제품에 적용 가능한 소재의 개발 및 제조가 필요하다. Influenza viruses such as new influenza (swine flu), which have recently shown contagious worldwide, Severe Acute Respiratory Syndrome (SARS, SARS-CoV), Middle East Respiratory Syndrome (MERS-CoV), and Coronavirus Infectious Disease-19 (Coronavirus) It is important to effectively block coronaviruses such as COVID-19. In particular, in the case of SARS and MERS in the past, there was no contagious ability without symptoms, but COVID-19 has a risk of being very contagious even when asymptomatic, and various mutations of the virus are occurring. Therefore, it is necessary to develop and manufacture materials that can be applied to products that can fundamentally block various viruses and mutant viruses, such as the emergence of new viruses.

수산화아파타이트는 바이러스나 바이러스의 근간이 되는 DNA나 RNA에 대하여 매우 강한 흡착 특성이 있고, 구리나 백금은 바이러스를 사멸화시킨다. 따라서 수산화아파타이트에 구리나 백금 이온을 담지시켜 바이러스를 흡착-차단하고 사멸-불활성화시켜 다양한 바이러스를 원천적으로 차단하는 것이 가능하다. Hydroxyapatite has very strong adsorption properties for viruses and the DNA or RNA that forms the basis of viruses, and copper and platinum kill viruses. Therefore, it is possible to fundamentally block various viruses by adsorbing and blocking viruses and killing and inactivating them by supporting copper or platinum ions on hydroxyapatite.

본 발명을 통해 다양한 바이러스를 원천적으로 차단하고 사멸화되는 복합 소재를 제조할 수 있어 마스크, 필터 등 위생/방역 관련 제품에 적용이 가능해 백신 및 치료제 등의 개발 기간 동안 효과적인 생활 방역이 가능하다. Through the present invention, it is possible to manufacture a composite material that fundamentally blocks and kills various viruses, so it can be applied to hygiene/quarantine-related products such as masks and filters, enabling effective quarantine in everyday life during the development period of vaccines and treatments.

도 1은, 실시예 1에 의해 제조된 수산화아파타이트의 X-선 회절 분석 결과를 나타내었다.
도 2는, 실시예 1에 의해 제조된 수산화아파타이트-백금이온 복합체 입자의 주사전자현미경 사진을 나타내었다.
도 3은, 실시예 2에 의해 제조된 수산화아파타이트-구리이온 복합체 입자의 주사전자현미경 사진을 나타내었다.
Figure 1 shows the results of X-ray diffraction analysis of hydroxyapatite prepared in Example 1.
Figure 2 shows a scanning electron microscope photograph of the hydroxyapatite-platinum ion composite particles prepared in Example 1.
Figure 3 shows a scanning electron microscope photograph of the hydroxyapatite-copper ion composite particles prepared in Example 2.

수산화칼슘 74.09g 및 85% 인산 115.3 ml (Ca/P 몰비 1.67) 그리고 염화제이백금 0.2g을 정량한 후에 혼합한다. 상기 혼합 용액을 혼합하면서 3M 수산화나트륨 수용액을 첨가하면서 pH 10으로 조절한다. 조절한 혼합 수용액을 1L Ball Mill Port에 첨가하고 1mm 및 3mm 크기의 지르코니아 볼을 각각 1kg 씩 넣고 Ball Mill의 온도가 60℃가 되도록 한 다음에 250RPM의 속도로 48시간 동안 Ball Mill 하였다. Ball Mill 반응 후에 여과 및 세척하고 150℃에서 15시간 동안 건조하였다. 건조한 복합체를 조분쇄 및 미분쇄하여 복합체 미분말을 얻었다. Weigh 74.09 g of calcium hydroxide, 115.3 ml of 85% phosphoric acid (Ca/P molar ratio 1.67), and 0.2 g of platinum chloride and mix them. While mixing the above mixed solution, the pH is adjusted to 10 by adding 3M sodium hydroxide aqueous solution. The adjusted mixed aqueous solution was added to the 1L Ball Mill Port, 1kg of 1mm and 3mm sized zirconia balls were added, the temperature of the ball mill was set to 60°C, and ball milled at a speed of 250RPM for 48 hours. After ball mill reaction, it was filtered, washed, and dried at 150°C for 15 hours. The dried composite was coarsely ground and finely ground to obtain composite fine powder.

제이인산칼슘 378.17g 및 수산화칼슘 111.15g (Ca/P 몰비 1.67) 그리고 염화구리 30g을 정량하고 혼합한다. 상기 혼합물에 증류수 500ml를 첨가하고 2L Ball Mill Port에 첨가하고 1mm, 3mm 및 5mm 크기의 알루미나 볼을 각각 0.9kg 씩 넣고 실온에서 280RPM의 속도로 Ball Mill을 48시간 동안 하였다. Ball Mill 반응 후에 여과 및 세척하고 120℃에서 24시간 동안 건조하였다. 건조한 복합체를 분쇄하여 복합체 미분말을 얻었다. Weigh and mix 378.17 g of dibasic calcium phosphate, 111.15 g of calcium hydroxide (Ca/P molar ratio 1.67), and 30 g of copper chloride. 500 ml of distilled water was added to the mixture, added to a 2L Ball Mill Port, 0.9 kg each of 1 mm, 3 mm, and 5 mm sized alumina balls were added, and ball milled at room temperature at a speed of 280 RPM for 48 hours. After the ball mill reaction, it was filtered, washed, and dried at 120°C for 24 hours. The dried composite was pulverized to obtain composite fine powder.

질산칼슘 236.15g 및 인산암모늄 73.37g (Ca/P 몰비 1.8) 그리고 염화구리 10g을 정량한 후에 혼합하고 2L Ball Mill Port에 넣는다. 증류수 1,000ml에 수산화나트륨 40g을 첨가한 알칼리 수용액 1,000ml을 2L Ball Mill Port에 넣은 후에 3mm 및 5mm 크기의 알루미나 볼을 각각 1.3 kg씩 넣고 200RPM의 속도로 12시간 동안 Ball Mill 하였다. Ball Mill 반응 후에 여과하고 150℃에서 10시간동안 건조한 다음 분쇄기를 이용하여 50um 이하의 미분말을 얻었다. After weighing 236.15 g of calcium nitrate, 73.37 g of ammonium phosphate (Ca/P molar ratio 1.8), and 10 g of copper chloride, mix and place in a 2L Ball Mill Port. 1,000 ml of an aqueous alkaline solution containing 40 g of sodium hydroxide added to 1,000 ml of distilled water was placed in a 2L Ball Mill Port, then 1.3 kg of 3 mm and 5 mm sized alumina balls were added and ball milled for 12 hours at a speed of 200 RPM. After the ball mill reaction, it was filtered and dried at 150°C for 10 hours, and fine powder of 50um or less was obtained using a grinder.

제이인산칼슘 344.18g 및 탄산칼슘 100.09g (Ca/P 몰비 1.67) 그리고 염화구리 20g을 정량하고 혼합한다. 상기 혼합물에 증류수 1,000ml를 첨가하고 교반하면서 1M 수산화나트륨 수용액을 첨가하면서 pH 10으로 조절한다. 상기 혼합 수용액을 2L Ball Mill Port에 첨가하고 1mm 알루미나 볼 1.3kg 및 3mm 알루미나볼 1kg를 넣고 실온에서 250RPM의 속도로 Ball Mill을 72시간 동안 하였다. Ball Mill 반응 후에 여과 및 세척하고 120℃에서 24시간 동안 건조하였다. 건조한 복합체를 분쇄하여 복합체 미분말을 얻었다. Weigh and mix 344.18 g of dibasic calcium phosphate, 100.09 g of calcium carbonate (Ca/P molar ratio 1.67), and 20 g of copper chloride. Add 1,000 ml of distilled water to the mixture and adjust the pH to 10 by adding 1 M aqueous sodium hydroxide solution while stirring. The mixed aqueous solution was added to a 2L Ball Mill Port, 1.3 kg of 1 mm alumina balls and 1 kg of 3 mm alumina balls were added, and ball milling was performed at room temperature at a speed of 250 RPM for 72 hours. After the ball mill reaction, it was filtered, washed, and dried at 120°C for 24 hours. The dried composite was pulverized to obtain composite fine powder.

Claims (10)

(1) 칼슘염 함유 물질 및 인산염 함유 물질 및 금속염을 혼합하는 단계
(2) 상기 혼합물에 수용액을 첨가하고 약산성에서 강알칼리성의 수용액이 되도록 조절하는 단계
(3) 상기 혼합물을 Ball Mill 시켜 반응시키는 단계
(4) 여과, 세척, 건조 및 분쇄하는 단계를 포함하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
(1) mixing a calcium salt-containing material, a phosphate-containing material, and a metal salt
(2) Adding an aqueous solution to the mixture and adjusting it to change from a weakly acidic to a strong alkaline aqueous solution.
(3) Ball milling the mixture to react
(4) Method for producing a complex of virus adsorption and killing functions, including the steps of filtration, washing, drying, and grinding.
제 1항에 있어서,
상기 (1) 단계에서 칼슘염 및 인산염의 농도비, 즉 Ca/P의 몰 비가 1.0 ~ 2.0인 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
Method for producing a complex with virus adsorption and killing functions, characterized in that the concentration ratio of calcium salt and phosphate, that is, the molar ratio of Ca / P in step (1) is 1.0 to 2.0.
제 1항에 있어서,
상기 (1) 단계에서 칼슘염 원료로서 수산화칼슘, 탄산칼슘, 염화칼슘, 질산칼슘, 산화칼슘, 황산칼슘, 규산칼슘, 글루콘산칼슘, 비산칼슘, 아세트산칼슘, 브로화칼슘, 글리세른인산칼슘, 젖산칼슘, 구연산칼슘, 피로피온산칼슘, 아스코트빈산칼슘 및 그들의 무수화물 및 수화물, 사칼슘인산염, 인산삼칼슘, 인산팔칼슘, 이수화인산디칼슘, 인산이칼슘, 피로인산칼슘, 이수화칼슘피로인산, 인산이수소칼슘, 메타인산칼슘 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
In step (1), calcium salt raw materials include calcium hydroxide, calcium carbonate, calcium chloride, calcium nitrate, calcium oxide, calcium sulfate, calcium silicate, calcium gluconate, calcium arsenate, calcium acetate, calcium broride, calcium glycerin phosphate, and calcium lactate. , calcium citrate, calcium pyropiionate, calcium ascotate and their anhydrates and hydrates, tetracalcium phosphate, tricalcium phosphate, octalcalcium phosphate, dicalcium phosphate dihydrate, dicalcium phosphate, calcium pyrophosphate, dihydrate calcium pyrophosphate, Method for producing a complex with virus adsorption and killing function, characterized by calcium dihydrogen phosphate and calcium metaphosphate
제 1항에 있어서,
상기 (1) 단계에서 인산염 원료로서 오르토인산, 오산화인, 제일인산암모늄, 제이인산암모늄, 메타인산, 피로인산, 제이인산나트륨, 삼인산, 사인산, 제이인산칼륨, 제이인산마그네슘, 제삼인삼칼륨, 제삼인산나트륨, 제일인산나트륨, 제일인산칼륨, 염화포스포릴, 폴리메타인산, 제삼인산마그네슘, 사칼슘인산염, 인산삼칼슘, 인산팔칼슘, 이수화인산디칼슘, 인산이칼슘, 피로인산칼슘, 이수화칼슘피로인산, 인산이수소칼슘, 메타인산칼슘인 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
In step (1), the phosphate raw materials include orthophosphoric acid, phosphorus pentoxide, monobasic ammonium phosphate, dibasic ammonium phosphate, metaphosphoric acid, pyrophosphoric acid, sodium diphosphate, triphosphoric acid, phosphoric acid, potassium diphosphate, magnesium diphosphate, tripotassium phosphate, Sodium phosphate tribasic, sodium phosphate monobasic, potassium phosphate monobasic, phosphoryl chloride, polymetaphosphate, magnesium triphosphate, tetracalcium phosphate, tricalcium phosphate, octalcalcium phosphate, dicalcium phosphate dihydrate, dicalcium phosphate, calcium pyrophosphate, dihydrate. Method for producing a complex with virus adsorption and killing function, characterized by calcium pyrophosphate, calcium dihydrogen phosphate, and calcium metaphosphate.
제 1항에 있어서,
상기 (1) 단계에서 금속염 원료로서 구리 화합물, 백금 화합물을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
Method for producing a complex with virus adsorption and killing functions characterized by copper compounds and platinum compounds as metal salt raw materials in step (1) above.
제 1항에 있어서,
상기 (1) 단계에서 금속염의 함유량은 칼슘염 및 인산염의 총중량의 0.1 ~ 30%인 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
A method for producing a complex with virus adsorption and killing functions, characterized in that the content of the metal salt in step (1) is 0.1 to 30% of the total weight of the calcium salt and phosphate.
제 1항에 있어서,
상기 (2) 단계에서 약산성 또는 강알칼리성의 수용액의 pH가 pH 6.0 ~ pH 14.0인 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
A method for producing a complex with virus adsorption and killing functions, characterized in that the pH of the weakly acidic or strongly alkaline aqueous solution in step (2) is pH 6.0 to pH 14.0.
제 1항에 있어서,
상기 (2) 단계에서 알칼리성 공급원으로서 수산화나트륨, 수산화칼륨, 암모니아, 수산화리튬, 수산화칼슘, 수산화마그네슘인 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
A method for producing a complex with virus adsorption and killing functions, characterized in that the alkaline source in step (2) is sodium hydroxide, potassium hydroxide, ammonia, lithium hydroxide, calcium hydroxide, and magnesium hydroxide.
제 1항에 있어서,
상기 (3) 단계에서 Ball Mill 온도를 10℃ ~ 110℃로 하여 반응시키는 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
A method for producing a complex with virus adsorption and killing functions, characterized in that the reaction is carried out at a ball mill temperature of 10 ℃ to 110 ℃ in step (3).
제 1항에 있어서,
상기 (3) 단계에서 Ball Mill 시간을 1시간 ~ 240시간 동안 반응시키는 것을 특징으로 하는 바이러스 흡착 및 사멸화 기능의 복합체 제조방법
According to clause 1,
A method for producing a complex with virus adsorption and killing functions, characterized in that the ball mill reaction is performed for 1 hour to 240 hours in step (3).
KR1020200102845A 2020-08-15 2020-08-15 Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function KR102605808B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200102845A KR102605808B1 (en) 2020-08-15 2020-08-15 Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200102845A KR102605808B1 (en) 2020-08-15 2020-08-15 Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function

Publications (2)

Publication Number Publication Date
KR20220021915A KR20220021915A (en) 2022-02-22
KR102605808B1 true KR102605808B1 (en) 2023-11-23

Family

ID=80494507

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200102845A KR102605808B1 (en) 2020-08-15 2020-08-15 Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function

Country Status (1)

Country Link
KR (1) KR102605808B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008069048A (en) 2006-09-14 2008-03-27 Fujifilm Corp Hydroxyapatite particle, hydroxyapatite particle dispersion, and method for producing hydroxyapatite film from either of them
JP2012095969A (en) 2010-11-05 2012-05-24 Hitachi Chemical Co Ltd Compound base material and manufacturing method of the same
WO2020157268A1 (en) * 2019-02-01 2020-08-06 Omya International Ag Production of surface-reacted calcium salts by grinding induced conversion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501674B1 (en) * 2002-12-12 2005-07-20 성윤모 Synthesis of Hydroxyapatite Composite Nanopowder Using Co-precipitation
KR100495517B1 (en) * 2003-05-26 2005-06-14 요업기술원 Preparation of Silver doped Hydroxyapatite with enduring antimicrobial effect and whiteness
KR100593262B1 (en) * 2003-08-28 2006-06-26 재단법인서울대학교산학협력재단 Methods for the manufacturing of apatite powders
KR100647220B1 (en) * 2003-11-22 2006-11-23 주식회사 코드바이오 Method for producing inorganic antibacterial materials
KR101336822B1 (en) * 2011-03-10 2013-12-04 (주)유성테크 Manufacturing method of Inorganic antibiotics
KR101457024B1 (en) * 2013-01-08 2014-10-31 (주)경동하이테크 Method for manufacturing multi-functional ceramic power and multi-functional ceramic power manufactured by the method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008069048A (en) 2006-09-14 2008-03-27 Fujifilm Corp Hydroxyapatite particle, hydroxyapatite particle dispersion, and method for producing hydroxyapatite film from either of them
JP2012095969A (en) 2010-11-05 2012-05-24 Hitachi Chemical Co Ltd Compound base material and manufacturing method of the same
WO2020157268A1 (en) * 2019-02-01 2020-08-06 Omya International Ag Production of surface-reacted calcium salts by grinding induced conversion

Also Published As

Publication number Publication date
KR20220021915A (en) 2022-02-22

Similar Documents

Publication Publication Date Title
Li et al. Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite
Kannan et al. Synthesis, mechanical and biological characterization of ionic doped carbonated hydroxyapatite/β-tricalcium phosphate mixtures
CN103977846B (en) A kind of by coal ash for manufacturing for the method for zeolite phosphor-curing agent and the product prepared in this way
JP6318282B1 (en) Method for preparing tetracalcium phosphate
KR102605808B1 (en) Composite Materials Manufacturing Method for Viruses Adsorption - Blocking and Apoptosis-Inactivation Function
CN101785860B (en) Tegafur/layered duplex metal hydroxide nanometer hybrid and preparation method thereof
ES2705166T3 (en) Method to remove heavy metals from silicate sources during the manufacture of a silicate
Li et al. Mechanism on releasing and solubilizing of fish bone calcium during nano‐milling
KR102101215B1 (en) Deodorant composition for spraying and method for producing the same
Groenke et al. Structural characterization, solution stability, and potential health and environmental effects of the Nano-TiO 2 bioencapsulation matrix and the model product of its biodegradation TiBALDH
JP5822296B2 (en) Silver ion antibacterial liquid production method, silver ion antibacterial liquid produced by the method, or silver ion antibacterial powder production method, silver ion antibacterial powder produced by the method
KR101017815B1 (en) Calcium Phosphate Particle Manufacture Methods for Solution Growth Method
Nisa et al. Fabrication and characterization of HA-oyster shell based on biopolymer-propolis as an agent of dental enamel remineralization material
KR101102429B1 (en) Sericite exchanged metal ion having anti-bacteria and preparing methods for thereof
Mulongo-Masamba et al. Synthesis and characterization of new β-chitin/calcium phosphate (DCPA) based composite using natural resources for environmental application
JP2018065715A (en) Process for producing hydroxyapatite
JP3918646B2 (en) Heavy metal treatment agent comprising metal-containing amine phosphate and method for immobilizing heavy metal using the same
JPS6036404A (en) Dental composition
JP4638979B2 (en) Silica-containing apatite
RU2179954C1 (en) Composition for treatment of natural water and waste waters and a method for preparing composition for treatment of natural and waste waters
RU2714188C1 (en) Method of producing colored single-phase calcium pyrophosphate
JP7244901B2 (en) Hydroxyapatite, method for producing same, and method for producing β-TCP
JPH09175806A (en) Preparation method for whitrockite having non-stoichiometric composition by liquid phase reaction
Cardoso et al. Layered double hydroxides for controlled fluoride release
Alshahrani et al. In Vitro Bioactivity Study on ZnI2-HAp Nanoparticles

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant